Fluvoxin the 1st specific anti-obsessive therapy. First SSRI approved by US FDA to treat OCD in children and adolescents. Significantly improves obsessive compulsive symptoms. First SSRI that offers a favourable tolerability profile. Lower incidence of Sexual dysfunction. Effective adjuvant in Schizo-Obsessive Patients.
Abstract
Fluvoxamine Maleate, Symbiosis, Cartoon man standing outside a hedge maze with shearers and an orange line between himself and the maze (pointing him in or out).
